secwatch.observer — SEC 8-K summary
======================================

Issuer:     SYNLOGIC, INC. (SYBX)
CIK:        0001527599
Form:       8-K
Filed at:   2022-09-06T23:59:59+00:00
Accession:  0001193125-22-238450
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Synlogic achieves second research milestone under Roche IBD collaboration
-------------------------------------------------------------------------

- Second pre-specified milestone earned; milestone payment triggered under Roche collaboration.
- First milestone was achieved and payment earned in September 2021.
- Collaboration Agreement signed June 2021; Roche has exclusive option to negotiate a license after research period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527599/000119312522238450/0001193125-22-238450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527599/000119312522238450/d373052d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-238450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer